Publikationsdatum:
2014-04-11
Beschreibung:
Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma Cell Death and Disease 5, e1160 (April 2014). doi:10.1038/cddis.2014.125 Authors: C D Hudson, T Hagemann, S J Mather & N Avril
Schlagwort(e):
receptor tyrosine kinase inhibitorpancreatic adenocarcinomaPI3K/Aktglycolysisdrug resistancemolecular targeted therapies
Digitale ISSN:
2041-4889
Thema:
Biologie
,
Medizin
Permalink